SCHEMBL12128403

SCHEMBL12128403

CCC1CCN(C(=O)CCN(C)C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
GNAI3 P08754 5/20 0.39
GNAO1 P09471 5/20 0.39
GNAI1 P63096 5/20 0.39
ITGB3 P05106 2/20 0.38
ITGA2B P08514 2/20 0.38
SIGMAR1 Q99720 1/20 0.37
TACR3 P29371 1/20 0.37
ALDH1A1 P00352 1/20 0.36
F2R P25116 1/20 0.36
HSD11B1 P28845 1/20 0.36
CHRNB2 P17787 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424637 0.90 NPC1 (0.46) NPC1GNAI3GNAO1GNAI1ITGB3
SCHEMBL24491469 0.88 CHRNB2 (0.41) DPP8DPP7MEN1POLBMAPT
SCHEMBL11892685 0.84 CHRNB2 (0.49) DPP8DPP7MEN1POLBMAPT
SCHEMBL25477547 0.83 DPP8 (0.42) DPP8DPP7MEN1POLBMAPT
SCHEMBL24456619 0.83 DPP8 (0.42) DPP8DPP7MEN1POLBMAPT
SCHEMBL25633195 0.80 CHRNB2 (0.46) DPP8DPP7MEN1POLBMAPT
SCHEMBL16015437 0.80 CHRNB2 (0.46) DPP8DPP7MEN1POLBMAPT
SCHEMBL27000074 0.80 CHRM2 (0.47) MEN1POLBMAPTKMT2ANPC1
SCHEMBL16230440 0.79 NPC1 (0.55) DPP8DPP7MEN1POLBMAPT
SCHEMBL24456539 0.79 DPP8 (0.47) DPP8DPP7MEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354540-B2 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA INC. (US) 2013-01-15 US disclosed
US-20110281874-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2011-11-17 US disclosed
US-8022223-B2 2-aminopyridine analogs as glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090156603-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156603-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS GCK, GCKR, PRKCSH DPP8 271/4885DPP7 67/4885MEN1 1943/4885
US-20110281874-A1 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS GCK, GCKR, GALK1 DPP8 172/4885DPP7 94/4885MEN1 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.